Sign in / Join Now
ETFs & Funds
, korlym sales seemed pretty weak taking in consideration it is a orphan drug indication. Neutral.
Add a reply...
Latest StockTalks »
people get CORT breaking news and analysis by email alert.
Get email alerts on CORT »
Corcept Therapeutics Incorporated
Get latest price
From other sites
Commit To Purchase Corcept Therapeutics At $7, Earn 10.8% Annualized Using Options
at TheStreet (Nov 7, 2016)
Edwards Lifesciences, DaVita HealthCare Partners, Corcept Therapeutics and CryoLife highlighted as Zacks Bull and Bear of the Day
at Zacks.com (Sep 22, 2016)
Zacks.com featured highlights: Corcept Therapeutics, Parsley Energy, TRI Pointe Group, NuVasive and Facebook
at Zacks.com (Sep 6, 2016)
Why Corcept Therapeutics (CORT) Could Be a Potential Winner
at Zacks.com (Aug 9, 2016)
Zacks.com featured highlights: Logitech International SA, A10 Networks, TriNet Group, Corcept Therapeutics and Antero Resources
at Zacks.com (Aug 8, 2016)